OptimizeRx to Host Online Session with Clinical Leaders at Microsoft, Massachusetts General Hospital and BD
18 März 2020 - 1:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies and payers, will host
an online discussion on how to navigate the Coronavirus (COVID-19)
pandemic with clinical leaders at Microsoft, Massachusetts General
Hospital and from the global medical technology company, BD.
The conversation is part of OptimizeRx’s initiative to
facilitate industry collaboration to help stop the spread of the
virus.
The panel will be moderated by Rebecca Love, MSN, RN and VP of
customer strategy and engagement for OptimizeRx. She will be joined
by Molly McCarthy MBA, BSN, Microsoft’s national director for U.S.
Health and chief nursing officer; Kelly Robke MBA, MS, RN, VP of
clinical thought leadership at BD; and Hiyam Nadel MBA, BSN,
director of the Center of Innovations in Care Delivery at
Massachusetts General Hospital.
Topic: Learning Together: Navigating the COVID-19
PandemicThis webinar is designed to share the knowledge,
insight and expertise of these leading nurse executives as they
navigate the COVID-19 pandemic. Connected by their nursing
backgrounds and representing three different healthcare verticals
(hospitals, healthcare technology and medical devices), this unique
panel will provide a valuable opportunity for participants to learn
and engage.Date: Thursday, March
19Time: 3:00 p.m. ET
The webinar is free and open to anyone in the industry and will
provide an opportunity to communicate directly with the panelists.
Over the coming weeks, OptimizeRx plans to host a series of crucial
conversations connecting various healthcare stakeholders to drive
innovation, collaboration and education.
Register today at www.optimizerx.com/webinars.
For more information about OptimizeRx’s webinar sessions,
contact media relations at (754) 245-7070 or
malejandra@optimizerx.com.
About OptimizeRxOptimizeRx® (NASDAQ: OPRX), a
digital health company, connects pharmaceutical companies to
patients and providers, offering greater affordability, adherence
and brand awareness at the point-of-care. As the nation’s largest
digital platform connecting life sciences to the point-of-care,
OptimizeRx provides a direct channel for pharma companies, payers,
medtech, and medical associations to communicate with healthcare
providers right within their workflow and also directly to
patients.
The cloud-based solution supports patient adherence to
medications and better healthcare outcomes with real-time access to
financial assistance, prior authorization, education and critical
clinical information. OptimizeRx provides more than half of the
ambulatory patient market with access to these benefits through
leading EHR platforms like Allscripts, Amazing Charts and Quest,
and directly via its mobile communications platform and digital
therapeutics SaaS platform.
For more information, follow the company on Twitter, LinkedIn or
visit www.OptimizeRx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
OptimizeRx Contact Doug Baker, CFOTel (248)
651-6568 x807 dbaker@optimizerx.com
Media Relations Contact Maira Alejandra, Media
Relations ManagerTel (754) 245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both, CMATel
(949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024